UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO ® and OTEMTO ® studies: a subgroup analysis by age

International journal of chronic obstructive pulmonary disease, 2016, Vol.11 (1), p.2701-2710

2016

Volltextzugriff (PDF)

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

Respiratory research, 2008-11, Vol.9 (1), p.73-73, Article 73

2008

Volltextzugriff (PDF)

Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD

Respiratory medicine, 2014-02, Vol.108 (2), p.366-375

2014

Volltextzugriff (PDF)

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies

NPJ primary care respiratory medicine, 2017-02, Vol.27 (1), p.7-9, Article 7

2017

Volltextzugriff (PDF)

Ciclesonide Reduces the Need for Oral Steroid Use in Adult Patients With Severe, Persistent Asthma

Chest, 2006-05, Vol.129 (5), p.1176-1187

2006

Volltextzugriff (PDF)

Differences in physicians’ self-reported knowledge of, attitudes toward, and responses to the black box warning on long-acting β-agonists

Annals of allergy, asthma, & immunology, 2009-10, Vol.103 (4), p.304-310

2009

Volltextzugriff (PDF)

Once-Daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use

Journal of allergy and clinical immunology, 2014-02, Vol.133 (2), p.AB5-AB5

2014

Volltextzugriff (PDF)

Profile of ciclesonide for the maintenance treatment of asthma

Therapeutics and clinical risk management, 2011-01, Vol.7 (default), p.351-358

2011

Volltextzugriff (PDF)

Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma

Current medical research and opinion, 2007-11, Vol.23 (11), p.2897-2911

2007

Volltextzugriff (PDF)

Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma

Annals of allergy, asthma, & immunology, 2010-12, Vol.105 (6), p.465-470

2010

Volltextzugriff (PDF)

The Effect of Roflumilast on Lung Function: Pooled Results From Seven 6-Month Studies in Subjects With Moderate-to-Severe COPD

Chest, 2012-10, Vol.142 (4), p.690A-690B

2012

Volltextzugriff (PDF)

Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma

Respiratory medicine, 2007-03, Vol.101 (3), p.628-637

2007

Volltextzugriff (PDF)

Analysis of COPD Exacerbations Based on Two Operational Definitions in the Pivotal Trials of Roflumilast

Chest, 2011-10, Vol.140 (4), p.554A-554B

2011

Volltextzugriff (PDF)

Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma

The Annals of pharmacotherapy, 2005-12, Vol.39 (12), p.1977-1983

2005

Volltextzugriff (PDF)

Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids

Current medical research and opinion, 2005-08, Vol.21 (8), p.1281-1289

2005

Volltextzugriff (PDF)

Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma

Pulmonary pharmacology & therapeutics, 2008-08, Vol.21 (4), p.630-636

2008

Volltextzugriff (PDF)

A Comparison of Ipratropium and Albuterol vs Albuterol Alone for the Treatment of Acute Asthma

Chest, 1996-09, Vol.110 (3), p.611-616

1996

Volltextzugriff (PDF)

The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma : A pooled analysis of three trials

Chest, 1998-08, Vol.114 (2), p.365-372

1998

Volltextzugriff (PDF)

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma

Journal of allergy and clinical immunology, 2000-11, Vol.106 (5), p.852-860

2000

Volltextzugriff (PDF)

Lung Function Response With Tiotropium + Olodaterol Maintenance Treatment in Patients With COPD in the TONADO and OTEMTO Studies: A Subgroup Analysis by Age

Chest, 2015-10, Vol.148 (4), p.740A-740B

2015

Volltextzugriff (PDF)

Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD

Respiratory medicine, 2013-06, Vol.107 (6), p.854-862

2013

Volltextzugriff (PDF)

Lung Cancer in Patients With Immunodeficiency Syndrome

Chest, 1993-02, Vol.103 (2), p.410-413

1993

Volltextzugriff (PDF)

An easy-to-use dry-powder inhaler

Advances in therapy, 2000-11, Vol.17 (6), p.282-286

KARPEL, Jill P

2000

Volltextzugriff (PDF)

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies

NPJ primary care respiratory medicine, 2020-12, Vol.30 (1), p.53, Article 53

2020

Volltextzugriff (PDF)

SMALL AIRWAY FUNCTION IS CONSISTENTLY IMPROVED IN ASTHMA PATIENTS TREATED WITH MOMETASONE FUROATE DELIVERED BY A DRY POWDER INHALER

Chest, 2009-10, Vol.136 (4), p.10S-10S

2009

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO ® and OTEMTO ® studies: a subgroup analysis by age

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies

Ciclesonide Reduces the Need for Oral Steroid Use in Adult Patients With Severe, Persistent Asthma

Differences in physicians’ self-reported knowledge of, attitudes toward, and responses to the black box warning on long-acting β-agonists

Once-Daily Tiotropium Respimat® Improves Lung Function In Patients With Severe Symptomatic Asthma Independent Of Leukotriene Modifier Use

Profile of ciclesonide for the maintenance treatment of asthma

Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma

Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma

The Effect of Roflumilast on Lung Function: Pooled Results From Seven 6-Month Studies in Subjects With Moderate-to-Severe COPD

Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma

Analysis of COPD Exacerbations Based on Two Operational Definitions in the Pivotal Trials of Roflumilast

Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma

Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids

Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma

A Comparison of Ipratropium and Albuterol vs Albuterol Alone for the Treatment of Acute Asthma

The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma : A pooled analysis of three trials

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma

Lung Function Response With Tiotropium + Olodaterol Maintenance Treatment in Patients With COPD in the TONADO and OTEMTO Studies: A Subgroup Analysis by Age

Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD

Lung Cancer in Patients With Immunodeficiency Syndrome

An easy-to-use dry-powder inhaler

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies

SMALL AIRWAY FUNCTION IS CONSISTENTLY IMPROVED IN ASTHMA PATIENTS TREATED WITH MOMETASONE FUROATE DELIVERED BY A DRY POWDER INHALER

Suchergebnisse filtern